Observational studyJournal of psychosomatic research2025
Telehealth provision of Retraining and Control Therapy (ReACT) on cognitive and biopsychosocial functioning in pediatric functional neurological disorder.
Observational study in Journal of psychosomatic research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Unmet needs in functional neurological disorder related to digital healthcare.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2026Review
- Retraining and control therapy: sense of control and catastrophic symptom expectations as targets of a cognitive behavioral treatment for pediatric functional seizures.Frontiers in psychiatry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
introductionRetraining and Control Therapy (ReACT) has been shown to improve functional seizure (FS) frequency. This prospective observational study evaluated the effects of ReACT on mixed functional neurological disorder (FND) symptoms and the maintenance of outcomes 6-months post-treatment. We hypothesized that all mixed FND symptoms and other biopsychosocial outcomes would improve following ReACT.
methodsAdolescents ages 11-18 with FS completed one in-person and 11 telehealth ReACT sessions. Participants self-reported FS frequency for 30-days pre-treatment, 30-days post-treatment, and 30-days at 6-months post-treatment. Cognitive performance was assessed at baseline and 1-week post-treatment. Other biopsychosocial assessments and FND symptoms were self-reported at baseline, 1-week post-treatment, and 6-months post-treatment. Descriptive statistics assessed changes in FND symptoms. Paired-samples t-tests and ANOVAs assessed changes in cognitive and biopsychosocial outcomes.
resultsThe final sample included 34 consecutively enrolled adolescents (82.4 % Female sex; 70.6 % White; M
conclusionAt 6-months post-ReACT, adolescents with FND experienced broad functional and biopsychosocial improvements. Telehealth provision demonstrates the potential to expand treatment access.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.